Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | ADH1B | P00325 | 1/20 | 0.39 |
| ▸ | ADH1C | P00326 | 1/20 | 0.39 |
| ▸ | ADH1A | P07327 | 1/20 | 0.39 |
| ▸ | ADH4 | P08319 | 1/20 | 0.39 |
| ▸ | ADH7 | P40394 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.37 |
| ▸ | FDPS | P14324 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18898174 | 1.00 | DNM1 (0.46) | DNM1EPHX1LMNATSHRTHRB | |
| SCHEMBL19890567 | 1.00 | DNM1 (0.46) | DNM1EPHX1LMNATSHRTHRB | |
| SCHEMBL21890305 | 0.98 | DNM1 (0.50) | DNM1EPHX1LMNATSHRTHRB | |
| SCHEMBL16649021 | 0.97 | DNM1 (0.42) | DNM1EPHX1LMNATSHRTHRB | |
| SCHEMBL8533031 | 0.95 | DNM1 (0.42) | DNM1EPHX1LMNATSHRTHRB | |
| SCHEMBL28177815 | 0.95 | DNM1 (0.42) | DNM1EPHX1LMNATSHRTHRB | |
| SCHEMBL9210833 | 0.95 | DNM1 (0.46) | DNM1EPHX1LMNATSHRADH1B | |
| SCHEMBL20299289 | 0.91 | DNM1 (0.42) | DNM1EPHX1LMNATSHRTHRB | |
| SCHEMBL5014624 | 0.91 | DNM1 (0.42) | DNM1EPHX1LMNATSHRTHRB | |
| SCHEMBL117274 | 0.91 | DNM1 (0.42) | DNM1EPHX1LMNATSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8003369-B2 | Bacteriolytic agent | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2011-08-23 | — | — | US | disclosed |
| US-7582694-B2 | Antimicrobial lubricant for wood fiber-plastic composites | LONZA, INC. (US) | 2009-09-01 | — | — | US | disclosed |
| US-20090143569-A1 | BACTERIOLYTIC AGENT | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2009-06-04 | — | — | US | disclosed |
| EP-1567586-B1 | ANTIMICROBIAL LUBRICANT FOR WOOD FIBER-PLASTIC COMPOSITES | LONZA AG (US) | 2008-01-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090143569-A1 | BACTERIOLYTIC AGENT | PRKCH, PRKCA, PRKCI | DNM1 1223/4885EPHX1 4663/4885LMNA 1735/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.